Patients will assess symptoms based on a brief questionnaire, the Daily Ascites Symptom Tracker (dAST). The dAST will be self-administered every night at home starting after informed consent is obtained and continuing through treatment and follow-up periods, using an electronic patient reported outcome app.
A research study app to provide information, obtain e-consent, and complete surveys...
This is a clinical study for Arthritis Innovation Corporation’s (AIC) new drug...
You will use this app to complete informed consent, complete a survey...
The Purpose 2 Study app will assist you with completing study surveys,...
The purpose of this study is to obtain input from parents that...
With this app you can access study information and visit instructions. The...
Created with AppPage.net
Similar Apps - visible in preview.